January 16, 2019 – Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s...
News | Thrombectomy Devices | January 16, 2019
January 16, 2019 — Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT...
News | Cath Lab | January 16, 2019
January 16, 2019 — Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational...
Sponsored Content
Feature | Sudden Cardiac Arrest | October 25, 2018
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to...
News | Structural Heart Occluders | January 16, 2019
January 16, 2019 — Abbott announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo...
A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor.
Blog | University of Colorado Hospital | January 16, 2019
In late December, I had the opportunity to conduct an onsite visit to the...
News | Heart Valve Technology | January 15, 2019
January 15, 2019 — Boston Scientific Corp. and Edwards Lifesciences Corp. announced that the companies have reached...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
The implantation of a MitraClip is guided under live transesophageal echo (TEE). This image shows the operator moving the open clip into position and engaging the mitral valve leaflets. The clip appears as an arrowhead shape in the ultrasound with the leaflets coming off each side. Photo from a MitraClip procedure at the University of Colorado Hospital.
Feature | Heart Valve Technology | January 14, 2019 | Allen Atchley, M.D., FACC, The Chattanooga Heart Institute
Mitral regurgitation (MR) is one of the most common types of heart valve diseases in the United States, affecting...
A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews.
Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.
In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S. government...
The startup company Genetesis introduced a new cardiac imaging modality it calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle.
Feature | AHA | January 14, 2019 | Dave Fornell, Editor
Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
An implanted ICD showing its three leads in the venous system.
Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
To extract or abandon broken or infected implantable, venous...
News | Womens Cardiovascular Health | January 11, 2019
January 11, 2019 — Research suggests that a gene that governs the body’s biological (circadian) clock acts...
News | Pharmaceuticals | January 10, 2019
January 10, 2019 — Aurobindo Pharma USA Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan...
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
Sponsored Content | Videos | January 10, 2019
...
News | Womens Cardiovascular Health | January 10, 2019
January 10, 2019 — The American Society of Echocardiography Foundation (ASEF) has partnered with WomenHeart: The...
